Faculty of Pharmacy, at Zagazig University, Egypt.
Dr. Galal Yahya is an Egyptian microbiologist and immunologist specializing in infection biology and molecular microbiology. Currently an Associate Professor at Zagazig University, Egypt, he has also held prestigious research positions in Spain and Germany. With a Ph.D. in Biomedicine and Molecular Cell Biology from the University of Barcelona (IBMB-CSIC), his research focuses on antimicrobial resistance, infection biology, and immunology. Dr. Yahya has contributed significantly to understanding microbial pathogenesis and innovative treatment strategies. He has been awarded the Alexander von Humboldt Postdoctoral Fellowship and has worked extensively in molecular genetics and microbiology. Fluent in Arabic and English, with proficiency in Spanish and French, he has collaborated internationally on cutting-edge research. His publications in high-impact journals reflect his dedication to scientific excellence. Currently based in Barcelona, Spain, Dr. Yahya continues to advance microbiology and immunology through his research and academic contributions.
Professional Profile
Scopus
ORCID
Education 🎓
Dr. Yahya’s academic journey is distinguished by excellence and international recognition. He earned his B.Sc. in Pharmaceutical Science from Zagazig University, Egypt, in 2006, where he graduated with honors. In 2011, he obtained a Master’s degree (DEA) in Biochemistry and Molecular Biology from the University of Lleida, Spain, achieving the highest distinction (Excellent cum laude). His Ph.D. in Biomedicine and Molecular Cell Biology of Cancer was awarded in 2016 by the University of Barcelona (IBMB-CSIC), also with the highest honor. His doctoral research provided groundbreaking insights into microbial cell cycle regulation. His educational background laid a strong foundation for his specialization in infection biology, microbiology, and immunology. His academic achievements reflect his deep commitment to scientific inquiry and biomedical advancements, shaping his career as a leading researcher in microbiology.
Professional and Research Experience 🔬
Dr. Yahya’s professional career spans leading research institutions across Egypt, Spain, and Germany. He began as a Demonstrator (2007-2009) at the Department of Microbiology and Immunology, Zagazig University. His Ph.D. research took place in Marti Aldea Lab at the University of Lleida and IBMB-CSIC in Barcelona (2009-2016), where he explored microbial cell biology. In 2016, he became a Lecturer at Zagazig University and later secured the prestigious Alexander von Humboldt Postdoctoral Fellowship (2017-2021) at the Technical University of Kaiserslautern, Germany, focusing on molecular genetics. Since 2021, he has been an Associate Professor at Zagazig University, contributing to microbiology research and education. In 2023-2024, he served as a Senior Postdoctoral Investigator at IBMB-CSIC, Barcelona, furthering his expertise in infection biology and antibiotic resistance. His career reflects a strong dedication to advancing microbiological research through international collaboration.
Research Interests 🔍
Dr. Yahya’s research focuses on microbial infections, antimicrobial resistance, and immunology. His work explores innovative antifungal and antibacterial therapies, phage therapy, and biofilm inhibition strategies. He has a keen interest in host-pathogen interactions, molecular microbiology, and infection control mechanisms. His studies on phage-antibiotic synergy have paved the way for alternative treatments against multidrug-resistant bacteria. He is also involved in biotechnological applications, such as using microbes for self-healing concrete and sustainable environmental solutions. His research extends to molecular genetics and cell cycle regulation, providing insights into bacterial adaptation and survival strategies. Dr. Yahya’s interdisciplinary approach integrates microbiology, pharmacology, and biotechnology, addressing global health challenges. His expertise contributes to the development of novel therapeutic interventions to combat infectious diseases, making significant strides in microbiological research.
Awards and Recognitions 🏆
Dr. Yahya has received several prestigious awards recognizing his scientific contributions. Notably, he was awarded the Alexander von Humboldt Postdoctoral Fellowship (2017-2021) in Germany, a testament to his outstanding research in molecular microbiology. His Ph.D. dissertation earned Excellent cum laude distinction from the University of Barcelona, highlighting his academic excellence. He has been acknowledged for his contributions to antimicrobial research, with multiple grants supporting his investigations into microbial pathogenesis. Additionally, his research on phage therapy and antibiotic resistance has been recognized at international conferences. His work continues to shape the field of microbiology, earning him a place among leading researchers in infection biology. With numerous accolades, Dr. Yahya remains committed to advancing biomedical science and developing innovative solutions for infectious diseases.
Top Noted Publications 📚
Dr. Yahya has authored numerous research articles in high-impact journals, covering antimicrobial resistance, infection biology, and microbiological innovations. Some of his key publications include:
-
Innovative Antifungal Therapy: In Vivo Evaluation of 3-Ethyl-6,7-Dihydroxy-2-Phenyl-Chromen-4-One Purified from Alpinia officinarum on Cryptococcus neoformans
Journal: International Immunopharmacology
Year: 2025
Summary: This study investigates the antifungal efficacy of a compound isolated from Alpinia officinarum against Cryptococcus neoformans in vivo, suggesting potential therapeutic applications.
-
Comprehensive Review for Aflatoxin Detoxification with Special Attention to Cold Plasma Treatment
Journal: Mycotoxin Research
Year: 2025
Summary: This review discusses various aflatoxin detoxification methods, emphasizing the emerging role of cold plasma treatment as an effective strategy.
-
Utilizing Phage-Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug-Resistant Enterococcus faecalis
Journal: Microbial Biotechnology
Year: 2025
Summary: The research explores the combined use of bacteriophages and antibiotics to treat infections caused by multidrug-resistant Enterococcus faecalis in a mouse model, highlighting a potential therapeutic approach.
-
Silk Fibroin/Gelatin Electrospun Nanofibrous Dressing Loaded with Roxadustat Accelerates Wound Healing in Diabetic Rats
Journal: Journal of Drug Delivery Science and Technology
Year: 2025
Summary: This study evaluates a novel wound dressing composed of silk fibroin and gelatin nanofibers loaded with roxadustat, demonstrating enhanced wound healing in diabetic rat models.
-
Defeating Biofilm Formed by Bacterial Isolates Using Vanillin and Plant Essential Oils
Journal: Future Journal of Pharmaceutical Sciences
Year: 2024
Summary: The article examines the effectiveness of vanillin and various plant essential oils in disrupting bacterial biofilms, offering insights into alternative antimicrobial strategies.
-
Carbapenem-Resistant Acinetobacter baumannii Lytic Phage Therapy in a Mouse Model
Journal: Future Journal of Pharmaceutical Sciences
Year: 2024
Summary: This research assesses the therapeutic potential of lytic bacteriophages against carbapenem-resistant Acinetobacter baumannii infections in mice, indicating promising avenues for phage therapy.
-
Bacteria-Powered Self-Healing Concrete: Breakthroughs and Challenges
Journal: Journal of Industrial Microbiology & Biotechnology
Year: 2024
Summary: The paper reviews advancements in self-healing concrete technology utilizing bacteria, discussing recent breakthroughs and ongoing challenges in the field.
-
Eco-Smart Biocontrol Strategies Utilizing Potent Microbes
Journal: Biotechnology Reports
Year: 2024
Summary: This article explores environmentally friendly biocontrol methods employing effective microbial agents, highlighting sustainable approaches to pest and disease management.
-
Advances in Metal/Metal Oxide Nanoparticles for Antibiotic Resistance
Journal: International Journal of Molecular Sciences
Year: 2024
Summary: The study delves into the development of metal and metal oxide nanoparticles as novel solutions to combat antibiotic-resistant bacteria, presenting recent progress and applications.
-
Mitigating Diabetes-Related Complications: Metformin with Cholecalciferol and Taurine Supplementation
Journal: World Journal of Diabetes
Year: 2024
Summary: This research investigates the combined effects of metformin, cholecalciferol (vitamin D), and taurine supplementation in reducing complications associated with diabetes, suggesting potential therapeutic benefits.
Conclusion
Galal Yahya is a highly qualified candidate for the Best Researcher Award, given his strong academic background, international research collaborations, and significant contributions to microbiology and immunology. His publication record and research impact are impressive. Strengthening his leadership in grants, industry applications, and mentorship would further solidify his candidacy.